Pharma Mirror

JULY 23, 2020

DuPont Nutrition & Biosciences (DuPont) today announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University in New Jersey. The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation.

Research 130

Research Medicine 130

World of DTC Marketing

JULY 23, 2020

QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science. Some may think it’s a bad time to be launching a drug but actually the reverse may be true. Doctors who don’t work in hospitals have the time to engage with drug MLS people virtually and a lot of them are reviewing the drugs that “they tend to presc

Drugs 130

Drugs Production Marketing Branding 130

Camargo

JULY 23, 2020

The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo.

Development 130

Development 130

Delveinsight

JULY 23, 2020

The current Familial chylomicronemia syndrome market is mainly dominated by traditional TG-lowering agents, and as per DelveInsight analysis, the market worth was estimated to be USD 1.0 million in 2017. A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people ( Burnett and Hegele, 1999; Pouwels et al. 2008 ).

Marketing 61

Marketing Gene Therapy Drugs Genome 61

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Outsourcing Pharma

JULY 23, 2020

The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study.

Trials 61

Trials Research Clinical Development Development 61

Pharmacy Checkers

JULY 23, 2020

Last week , yet another state, New Hampshire hopped on the Canadian drug importation bandwagon. Joining Vermont, Florida, Colorado, Maine and New Mexico, New Hampshire passed a law that would permit registered wholesale pharmacies to import lower-cost drugs from registered Canadian wholesale pharmacies. I have supported the initiative from the beginning, when the National Academy for State Health Policy (NASHP) came out with model legislation on drug importation from Canada.

Drugs 52

Drugs Pharmacy Medicine Development 52

Triage Cancer

JULY 23, 2020

The Latest Information About Unemployment Insurance Benefits. More than 40 million people have lost their jobs since March of this year, due to the economic havoc brought by the COVID-19 pandemic. If you find yourself in the position where you have lost your job, you may be eligible for unemployment benefits. Unemployment benefits are a form of insurance payout.

52

52

Outsourcing Pharma

JULY 23, 2020

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

Life Science 52

Life Science Regulation Marketing 52

Forte Research Systems®

JULY 23, 2020

Providing interim HRPP support can help your team fill in staffing gaps while staying on top of research and moving protocols forward.

Research 52

Research 52

Outsourcing Pharma

JULY 23, 2020

A leader from the genetic services company discusses how use of telemedicine can help pull in patients and keep trials going.

Genetics 52

Genetics Trials Clinical Development Development 52

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

BioPharma Reporter

JULY 23, 2020

Gilead buys a stake in Tizona for its cancer immunotherapies, whilst holding the option to buy outright.

Regulation 52

Regulation Marketing 52

Syntegon Technology Pharma Blog

JULY 23, 2020

88

88

Delveinsight

JULY 23, 2020

Olema Oncology raises USD 54 Million for breast cancer program. Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas. The capital will bankroll a phase 1/2 study of the asset, OP-1250, as a single agent. Olema Oncology will assess the drug, a complete estrogen receptor antagonist, in patients with ER-positive, HER2-negative breast cancers that have come back despite other treatments or that have spread locally or to other

Protein 52

Protein Bacteria Scientist Research 52